Amsterdam UMC - Amsterdam Neuroscience

@amsneuroscience.bsky.social

๐Ÿง ๐Ÿ”ฌ Amsterdam Neuroscience is the research institute for neuroscience of Amsterdam UMC, VU Amsterdam and the University of Amsterdam. Our researchers and clinicians join forces in the field of fundamental, translational and clinical research.

๐Ÿง  ๐—•๐—ฟ๐—ฒ๐—ฎ๐—ธ๐˜๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต ๐˜๐—ฟ๐—ถ๐—ฎ๐—น @amsterdamumc.bsky.social ๐—ผ๐—ณ๐—ณ๐—ฒ๐—ฟ๐˜€ ๐—ณ๐—ถ๐—ฟ๐˜€๐˜ ๐—ต๐—ผ๐—ฝ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ฐ๐—ต๐—ถ๐—น๐—ฑ๐—ฟ๐—ฒ๐—ป ๐˜„๐—ถ๐˜๐—ต ๐—ฉ๐—ฎ๐—ป๐—ถ๐˜€๐—ต๐—ถ๐—ป๐—ด ๐—ช๐—ต๐—ถ๐˜๐—ฒ ๐— ๐—ฎ๐˜๐˜๐—ฒ๐—ฟ ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐Ÿ’ฌ Van der Knaap: โ€œ๐˜›๐˜ฉ๐˜ช๐˜ด ๐˜ช๐˜ด ๐˜ต๐˜ฉ๐˜ฆ ๐˜ง๐˜ช๐˜ณ๐˜ด๐˜ต ๐˜ต๐˜ช๐˜ฎ๐˜ฆ ๐˜ช๐˜ต ๐˜ฉ๐˜ข๐˜ด ๐˜ฃ๐˜ฆ๐˜ฆ๐˜ฏ ๐˜ด๐˜ฉ๐˜ฐ๐˜ธ๐˜ฏ ๐˜ต๐˜ฉ๐˜ข๐˜ต ๐˜ต๐˜ฉ๐˜ช๐˜ด ๐˜ง๐˜ข๐˜ต๐˜ข๐˜ญ ๐˜ค๐˜ฉ๐˜ช๐˜ญ๐˜ฅ๐˜ฉ๐˜ฐ๐˜ฐ๐˜ฅ ๐˜ฃ๐˜ณ๐˜ข๐˜ช๐˜ฏ ๐˜ฅ๐˜ช๐˜ด๐˜ฆ๐˜ข๐˜ด๐˜ฆ ๐˜ค๐˜ข๐˜ฏ ๐˜ฃ๐˜ฆ ๐˜ข๐˜ฎ๐˜ฆ๐˜ญ๐˜ช๐˜ฐ๐˜ณ๐˜ข๐˜ต๐˜ฆ๐˜ฅ.โ€ www.amsterdamumc.org/en/research/...

Breakthrough trial offers first hope for children with Vanishing White Matter disease | Amsterdam UMC

A team of researchers from the Amsterdam Leukodystrophy Center at Amsterdam UMC, led by Prof. Marjo van der Knaap, has published the first clinical evidence that the drug guanabenz may alter the cours...

amsterdamumc.org

๐Ÿ”ฌ Six projects have received a ZonMw grant within the ๐˜—๐˜ณ๐˜ฐ๐˜ฎ๐˜ช๐˜ด๐˜ช๐˜ฏ๐˜จ ๐˜๐˜ฏ๐˜ฏ๐˜ฐ๐˜ท๐˜ข๐˜ต๐˜ช๐˜ท๐˜ฆ ๐˜›๐˜ฉ๐˜ฆ๐˜ณ๐˜ข๐˜ฑ๐˜ช๐˜ฆ๐˜ด program, highlighting the strength of collaboration between @vuamsterdam.bsky.social and @amsterdamumc.bsky.social in Alzheimerโ€™s drug discovery. Read more about the projects: www.amsterdamumc.org/en/research/...

ZonMw awards highlight the strength of the collaboration between VU and Amsterdam UMC in Alzheimerโ€™s drug discovery | Amsterdam UMC

In total, six projects have received a ZonMw award within the Promising Innovative Therapies program. This program supports the development of new treatments targeting the underlying mechanisms of dem...

amsterdamumc.org

๐Ÿ‘ฉโ€๐Ÿซ Today at 15:45, Wilma Van de Berg will deliver her inaugural lecture, bringing together multiple perspectives on disease progression as the newly appointed ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ฒ๐˜€๐˜€๐—ผ๐—ฟ ๐—–๐—ฒ๐—น๐—น๐˜‚๐—น๐—ฎ๐—ฟ ๐—ก๐—ฒ๐˜‚๐—ฟ๐—ผ๐—ฑ๐—ฒ๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป, ๐—ฃ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐˜€๐—ผ๐—ปโ€™๐˜€ ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ at @vuamsterdam.bsky.social. Read more: www.amsterdamumc.org/en/research/...

Wilma Van de Berg looks at Parkinsonโ€™s disease through different lenses | Amsterdam UMC

With her expertise in neuropathology, biobanking, and high-end microscopy analysis of human brain tissue, Wilma Van de Berg aims to improve early diagnosis and develop disease-modifying therapies for Parkinsonโ€™s disease. In her inaugural lecture on December 18, 2025, Professor Wilma Van de Berg will bring together different perspectives on disease progression as the newly appointed Professor Cellular Neurodegeneration, Parkinsonโ€™s disease at the Vrije Universiteit Amsterdam.

amsterdamumc.org